camptothecin has been researched along with Leukemia P388 in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (14.71) | 18.7374 |
1990's | 18 (52.94) | 18.2507 |
2000's | 10 (29.41) | 29.6817 |
2010's | 1 (2.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gunatilaka, AA; Hoffmann, G; Johnson, RK; Kingston, DG; Samaranayake, G | 1 |
Lindley, JT; Ronman, PE; Wall, ME; Wani, MC | 1 |
Ejima, A; Kawato, Y; Matsumoto, K; Mitsui, I; Ohsuki, S; Sato, K; Sugimori, M; Tagawa, H; Uoto, K; Yasuoka, M | 1 |
Bisagni, E; Croisy, A; Janin, YL; Riou, JF | 1 |
Bodo, B; Cosson, JP; Jossang, A; Provost, J; Sévenet, T; Zahir, A | 1 |
Ejima, A; Hirota, Y; Kawato, Y; Mitsui, I; Ohsuki, S; Sato, K; Sugimori, M; Terasawa, H; Uoto, K | 1 |
Baguley, BC; Bu, X; Deady, LW; Denny, WA; Finlay, GJ | 1 |
Choe, YH; Greenwald, RB; Wu, D | 1 |
Fairchild, CR; Farnsworth, NR; Garcia, R; Graf, TN; Izydore, RA; Jiménez, F; Kim, NC; Kinghorn, AD; Kroll, DJ; Lee, D; Navarro, HA; Oberlies, NH; Phifer, SS; Rose, WC; Seo, EK; Soejarto, DD; Wall, ME; Wani, MC; Wild, R | 1 |
Baltas, M; Bedos-Belval, F; Delomenède, M; Duran, H; Gornitzka, H; Negre-Salvayre, A; Rakotondramanana, DL; Rasoanaivo, P | 1 |
Chrisafi, S; Digkas, E; Hatzimichail, A; Kareli, D; Lialiaris, T; Mantadakis, E; Passadaki, T; Vargemezis, V | 1 |
Dupon, C; Gabut, M; Kohlhagen, G; Pommier, Y; Soret, J; Stévenin, J; Tazi, J | 1 |
Antony, S; Gmeiner, WH; Kohlhagen, G; Liao, ZY; Pommier, Y; Sordet, O; Zhang, HL | 1 |
Bailly, C; Beauvillain, JC; Cuevas, C; Gallego, MA; Kluza, J; Loyens, A; Marchetti, P; Sousa-Faro, JM | 1 |
Creasey, WA; Gil, D; Richards, M; Tsou, KC | 1 |
Funk, LR; Hofmann, GA; Johnson, RK; Mattern, MR; McCabe, FL; Polsky, RM | 1 |
Comoe, L; Couprie, J; Desoize, B; Grondard, L; Jardillier, JC; Larsen, AK; Riou, JF | 1 |
Kumi, R; Perez-Soler, R; Poirot, K; Reddy, S; Sugarman, SM; Wasan, K; Zou, Y | 1 |
Choe, YH; Conover, CD; Gilbert, C; Greenwald, RB; Hsue, M; Lee, C; Martinez, A; Pendri, A; Wu, D; Xia, J | 1 |
Dodds, HM; Haaz, MC; Riou, JF; Rivory, LP; Robert, J | 1 |
Fukasawa, K; Komatani, H; Morita, M; Nishimura, S; Okura, A; Sakaizumi, N; Yoshida, E; Yoshinari, T | 1 |
Bailly, C; Bigg, DC; Coulomb, H; Dassonneville, L; Demarquay, D; Huchet, M; Lansiaux, A; Lavergne, O | 1 |
Bailly, C; Dassonneville, L; Facompré, M; Goossens, JF; Hénichart, JP | 1 |
Karaberis, E; Mourelatos, D | 1 |
Conover, CD; Greenwald, RB; Pendri, A; Shum, KL | 1 |
Pommier, Y; Takebayashi, Y; Urasaki, Y | 1 |
Ejima, A; Kawato, Y; Matsumoto, K; Ohsuki, S; Sugimori, M; Tagawa, H; Terasawa, H; Yasuoka, M | 1 |
Aonuma, M; Hirota, Y; Kawato, Y; Kuga, H; Sato, K | 1 |
Hofmann, GA; Johnson, RK; Mattern, MR; McCabe, FL | 1 |
Ross, WE; Sullivan, DM | 1 |
Eng, WK; Hertzberg, RP; Hofmann, GA; Johnson, RK; Mattern, MR; McCabe, FL; Tan, KB; Woessner, RD | 1 |
Eng, WK; Johnson, RK; Mattern, MR; McCabe, FL; Tan, KB | 1 |
Ejima, A; Kawato, Y; Matsumoto, K; Ohsuki, S; Sugimori, M; Tagawa, H; Terasawa, H | 1 |
Matsushita, M; Matsuzaki, T; Saito, H; Tsuruo, T; Yokokura, T | 1 |
1 review(s) available for camptothecin and Leukemia P388
Article | Year |
---|---|
Resistance to inhibitors of DNA topoisomerases.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Camptothecin; Carrier Proteins; Cell Cycle; Cell Line; Cricetinae; Cricetulus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Circular; DNA, Neoplasm; DNA, Single-Stranded; Drug Resistance; Humans; Intercalating Agents; Leukemia P388; Membrane Glycoproteins; Mice; Protein Binding; Subcellular Fractions; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1991 |
33 other study(ies) available for camptothecin and Leukemia P388
Article | Year |
---|---|
Bioactive ergost-5-ene-3 beta, 7 alpha-diol derivatives from Pseudobersama mossambicensis.
Topics: Animals; Antineoplastic Agents, Phytogenic; DNA Repair; Drug Screening Assays, Antitumor; Ergosterol; Leukemia P388; Mice; Plants; Saccharomyces cerevisiae | 1992 |
Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogues.
Topics: Animals; Camptothecin; Cells, Cultured; Chemical Phenomena; Chemistry; Leukemia P388; Mice | 1980 |
Antitumor agents. 7. Synthesis and antitumor activity of novel hexacyclic camptothecin analogues.
Topics: Animals; Antineoplastic Agents; Camptothecin; Drug Screening Assays, Antitumor; Leukemia P388; Mice; Neoplasms, Experimental; Polycyclic Compounds; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
DNA topoisomerase I inhibitors: cytotoxic flavones from Lethedon tannaensis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Flavonoids; Humans; KB Cells; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; New Caledonia; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Topoisomerase I Inhibitors | 1996 |
Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Irinotecan; Leukemia P388; Mice; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1998 |
Synthesis and cytotoxic activity of 7-oxo-7H-dibenz[f,ij]isoquinoline and 7-oxo-7H-benzo[e]perimidine derivatives.
Topics: Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Design; Drug Resistance, Neoplasm; Humans; Indicators and Reagents; Isoquinolines; Jurkat Cells; Leukemia P388; Lung Neoplasms; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Conformation; Molecular Structure; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Selective phenolic acylation of 10-hydroxycamptothecin using poly (ethylene glycol) carboxylic acid.
Topics: Acylation; Animals; Antineoplastic Agents; Camptothecin; Carboxylic Acids; Hydrogen Bonding; Hydroxyquinolines; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Neoplasms; Polyethylene Glycols; Rats; Tumor Cells, Cultured | 2003 |
Alvaradoins E-N, antitumor and cytotoxic anthracenone C-glycosides from the leaves of Alvaradoa haitiensis.
Topics: Animals; Anthracenes; Antineoplastic Agents, Phytogenic; Dominican Republic; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Models, Biological; Molecular Structure; Monosaccharides; Plant Leaves; Plants, Medicinal; Simaroubaceae; Structure-Activity Relationship | 2007 |
Synthesis of ferulic ester dimers, functionalisation and biological evaluation as potential antiatherogenic and antiplasmodial agents.
Topics: Animals; Antioxidants; Atherosclerosis; Cell Survival; Coumaric Acids; Dimerization; Endothelium, Vascular; Esters; Humans; Leukemia P388; Lipoproteins, LDL; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Thiobarbituric Acid Reactive Substances | 2007 |
Attenuation of cytogenetic effects by erythropoietin in human lymphocytes in vitro and P388 ascites tumor cells in vivo treated with irinotecan (CPT-11).
Topics: Adolescent; Adult; Animals; Antimutagenic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Proliferation; Cells, Cultured; Erythropoietin; Humans; In Vitro Techniques; Irinotecan; Leukemia P388; Lymphocytes; Mice; Mitosis; Mutagens; Recombinant Proteins; Sister Chromatid Exchange; Young Adult | 2010 |
Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.
Topics: Alternative Splicing; Animals; Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; Down-Regulation; Drug Resistance, Neoplasm; Exons; Gene Expression Regulation, Leukemic; Green Fluorescent Proteins; Leukemia P388; Luminescent Proteins; Mice; Nuclear Proteins; Phosphoproteins; Phosphorylation; Recombinant Fusion Proteins; RNA Splicing; RNA-Binding Proteins; Serine-Arginine Splicing Factors; Transcriptional Activation | 2003 |
A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Death; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; DNA, Single-Stranded; Drug Screening Assays, Antitumor; Fluorodeoxyuridylate; Fluorouracil; Leukemia P388; Mice; Quinazolines; Thiophenes; Thymidine; Thymidylate Synthase; Topoisomerase I Inhibitors | 2005 |
Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Membrane Permeability; Cell-Free System; Coumarins; Cytochromes c; Heterocyclic Compounds, 4 or More Rings; Humans; Isoquinolines; Leukemia P388; Lung Neoplasms; Membrane Potentials; Mice; Mitochondria; Mitochondrial Membranes; NIH 3T3 Cells; Rats | 2006 |
Action of (S)-10-hydroxycamptothecin on P388 leukemia and distribution of the drug in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; DNA, Neoplasm; Flow Cytometry; Leukemia P388; Leukemia, Experimental; Mice; Tissue Distribution | 1983 |
In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Survival; CHO Cells; Cricetinae; DNA Damage; Drug Resistance; Female; Irinotecan; Leukemia P388; Mice; Topotecan | 1993 |
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Benzophenanthridines; Camptothecin; Catalysis; Cattle; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type II; Drug Resistance; Fibrosarcoma; Intercalating Agents; Leukemia P388; Mice; Phenanthridines; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Humans; Leukemia L1210; Leukemia P388; Lipids; Metabolic Clearance Rate; Mice; Tissue Distribution; Tumor Cells, Cultured | 1996 |
Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Transport; Camptothecin; Colorectal Neoplasms; Humans; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Neoplasm Transplantation; Rats; Spectrometry, Mass, Fast Atom Bombardment; Tumor Cells, Cultured | 1998 |
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biotransformation; Camptothecin; Humans; Irinotecan; Leukemia P388; Microsomes, Liver; Tumor Cells, Cultured | 1998 |
A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbazoles; DNA Damage; DNA Topoisomerases, Type I; DNA, Complementary; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Rearrangement; Glucosides; Humans; Leukemia P388; Neoplasm Proteins; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase I Inhibitors | 1999 |
Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Survival; DNA Topoisomerases, Type I; DNA, Superhelical; Drug Resistance, Neoplasm; Enzyme Inhibitors; Leukemia P388; Mice; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1999 |
Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Calcium; Camptothecin; Cell Cycle; Cell Survival; DNA Fragmentation; Electrophoresis, Agar Gel; Enzyme Inhibitors; HL-60 Cells; Humans; Hydrogen-Ion Concentration; Leukemia P388; Topoisomerase II Inhibitors | 2000 |
Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Division; Drug Screening Assays, Antitumor; Epirubicin; Humans; Leukemia P388; Lymphocytes; Melphalan; Mice; Sister Chromatid Exchange | 2000 |
Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Delivery Systems; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Hydrolysis; Leukemia P388; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Polyethylene Glycols; Prodrugs; Rats; Solvents; Tumor Cells, Cultured | 1999 |
Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterations.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cricetinae; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Enzyme Stability; Humans; Inhibitory Concentration 50; Leukemia P388; Male; Mice; Point Mutation; Prostatic Neoplasms; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2000 |
Antitumor agents. V. Synthesis and antileukemic activity of E-ring-modified (RS)-camptothecin analogues.
Topics: Animals; Antineoplastic Agents; Camptothecin; Drug Screening Assays, Antitumor; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Tumor Cells, Cultured | 1992 |
Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; DNA Damage; DNA Replication; DNA, Single-Stranded; Irinotecan; Kinetics; Leukemia P388; Mice; RNA, Neoplasm; Thymidine; Topoisomerase I Inhibitors; Uridine | 1991 |
Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Gamma Rays; Leukemia P388; Mice; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 1991 |
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
Topics: Animals; Camptothecin; DNA; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Gene Rearrangement; Leukemia P388; Mice; Mice, Inbred DBA; RNA, Messenger; Tumor Cells, Cultured | 1990 |
Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.
Topics: Alleles; Amsacrine; Animals; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance; Gene Expression Regulation; Gene Rearrangement; Leukemia P388; Leukemia, Experimental; Methylation; Methyltransferases; Mice; RNA, Messenger; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic | 1989 |
Synthesis and antileukemic activity of (+-)-20-deoxyaminocamptothecin analogues.
Topics: Animals; Antineoplastic Agents; Camptothecin; Leukemia P388; Mice | 1989 |
Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Doxorubicin; Drug Resistance; Irinotecan; Leukemia P388; Neoplasms, Experimental; Tumor Cells, Cultured; Vincristine | 1988 |